Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1456 to 1470 of 1773 results for patient safety

  1. Dupilumab for treating moderate to severe prurigo nodularis (TA955)

    Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe prurigo nodularis in adults when systemic treatment is suitable.

    Technology appraisal guidance
    Published
    13 March 2024
    View recommendations

    Sections for TA955

  2. Photodynamic therapy for advanced bronchial carcinoma (HTG54)

    Evidence-based recommendations on photodynamic therapy for advanced bronchial carcinoma. This involves giving the patient something that makes them sensitive to light, then using special equipment to shine light onto the cancer to activate the substance and destroy some of the cancer.

    HealthTech guidance
    Published
    25 August 2004
    View recommendations

    Sections for HTG54

  3. Endovascular stent insertion for intracranial atherosclerotic disease should only be used in the context of research. Research should clearly define patient selection and be designed to provide outcome data based on follow-up of at least 2 years.

    only be used in the context of research. Research should clearly define patient selection and be designed to provide outcome data based...

    Research recommendation
    Published
    9 June 2015

  4. NICE encourages further research into radiofrequency treatment for haemorrhoids, preferably randomised controlled trials. It may update the guidance on publication of further evidence. Outcomes should include pain, secondary haemorrhage, recurrence rate, the need for repeat procedures and quality-of-life measures. Details of patient selection should also be reported.

    measures. Details of patient selection should also be reported. Any explanatory notes(if applicable) Current evidence on the...

    Research recommendation
    Published
    15 October 2018

  5. Further research into arthroscopic radiofrequency chondroplasty of the knee should clearly document patient selection and the types of chondral defects being treated. More evidence on long-term outcomes would be useful.

    arthroscopic radiofrequency chondroplasty of the knee should clearly document patient selection and the types of chondral defects being...

    Research recommendation
    Published
    9 June 2015

  6. Further research on unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's disease, which could include randomised controlled trials, should address patient selection and report on long-term follow-up.

    should address patient selection and report on long-term follow-up. Any explanatory notes(if applicable) Current evidence on the...

    Research recommendation
    Published
    13 November 2018

  7. Tixagevimab plus cilgavimab for preventing COVID-19 (TA900)

    Evidence-based recommendations on tixagevimab plus cilgavimab (Evusheld) for preventing COVID-19 in adults.

    Technology appraisal guidance
    Published
    14 June 2023
    View recommendations

    Sections for TA900

  8. Belantamab mafodotin with bortezomib and dexamethasone for previously treated multiple myeloma (TA1149)

    Evidence-based recommendations on belantamab mafodotin (Blenrep) with bortezomib and dexamethasone for previously treated multiple myeloma in adults.

    Technology appraisal guidance
    Published
    30 April 2026
    View recommendations

    Sections for TA1149

  9. Tuberculosis (NG33)

    This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults. It aims to improve ways of finding people who have TB in the community and recommends that everyone under 65 with latent TB should be treated. It describes how TB services should be organised, including the role of the TB control board.

    NICE guideline
    Last updated
    16 February 2024
    View recommendations

    Sections for NG33

  10. NICE encourages the peer-reviewed publication of all further research for percutaneous balloon valvuloplasty for fetal critical aortic stenosis. Further research could be in the form of controlled trials, analysis of registry data or other observational studies. It should address patient selection, timing of the intervention and the natural history of the disease.

    analysis of registry data or other observational studies. It should address patient selection, timing of the intervention and the...

    Research recommendation
    Published
    10 December 2018

  11. NICE encourages further research into the role of negative pressure wound therapy (NPWT) for the open abdomen. Patient selection should be documented and research should report on efficacy outcomes such as impact on wound care and healing rates, and duration of hospital stay.

    the role of negative pressure wound therapy (NPWT) for the open abdomen. Patient selection should be documented and research should...

    Research recommendation
    Published
    9 June 2015

  12. For people with severe and symptomatic tricuspid regurgitation, evidence on the efficacy of transcatheter tricuspid valve annuloplasty is limited in quantity and quality. Evidence on its safety shows there are serious but well-recognised complications. Therefore, for these people, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.

    tricuspid valve annuloplasty is limited in quantity and quality. Evidence on its safety shows there are serious but well-recognised...

    Research recommendation
    Published
    4 August 2022

  13. Well-controlled studies are needed to support the current limited evidence on weight loss in the short term. They should document patient selection, all complications (while the device is in place and after its removal) and technical problems associated with placing and removing the device.

    limited evidence on weight loss in the short term. They should document patient selection, all complications (while the device is in...

    Research recommendation
    Published
    9 June 2015

  14. Technology appraisal committee D members

    Find out more about NICE technology appraisals advisory committee D members

  15. Technology appraisal committee D members

    Find out more about NICE technology appraisals advisory committee D members